Cargando…

Targeting cPLA(2) derived lipid hydroperoxides as a potential intervention for sarcopenia

Defects in neuromuscular innervation contribute significantly to the age-related decline in muscle mass and function (sarcopenia). Our previous studies demonstrated that denervation induces muscle mitochondrial hydroperoxide production (H(2)O(2) and lipid hydroperoxides (LOOHs)). Here we define the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pharaoh, Gavin, Brown, Jacob L., Sataranatarajan, Kavithalakshmi, Kneis, Parker, Bian, Jan, Ranjit, Rojina, Hadad, Niran, Georgescu, Constantin, Rabinovitch, Peter, Ran, Qitao, Wren, Jonathan D., Freeman, Willard, Kinter, Michael, Richardson, Arlan, Van Remmen, Holly
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435184/ https://www.ncbi.nlm.nih.gov/pubmed/32811851 http://dx.doi.org/10.1038/s41598-020-70792-7

Ejemplares similares

Scavenging mitochondrial hydrogen peroxide by peroxiredoxin 3 overexpression attenuates contractile dysfunction and muscle atrophy in a murine model of accelerated sarcopenia
por: Ahn, Bumsoo, et al.
Publicado: (2022)

Metabolic and Stress Response Changes Precede Disease Onset in the Spinal Cord of Mutant SOD1 ALS Mice
por: Pharaoh, Gavin, et al.
Publicado: (2019)

Ablation of the mitochondrial complex IV assembly protein Surf1 leads to increased expression of the UPR(MT) and increased resistance to oxidative stress in primary cultures of fibroblasts
por: Pharaoh, Gavin, et al.
Publicado: (2016)

Restoration of SERCA ATPase prevents oxidative stress-related muscle atrophy and weakness
por: Qaisar, Rizwan, et al.
Publicado: (2018)

Lipid hydroperoxides and oxylipins are mediators of denervation induced muscle atrophy
por: Brown, Jacob L., et al.
Publicado: (2022)

Muscle mitochondrial catalase expression prevents neuromuscular junction disruption, atrophy, and weakness in a mouse model of accelerated sarcopenia
por: Xu, Hongyang, et al.
Publicado: (2021)

Restoration of Sarcoplasmic Reticulum Ca(2+) ATPase (SERCA) Activity Prevents Age-Related Muscle Atrophy and Weakness in Mice
por: Qaisar, Rizwan, et al.
Publicado: (2020)

Role of Signaling Molecules in Mitochondrial Stress Response
por: Hill, Shauna, et al.
Publicado: (2018)

Cancer cachexia in a mouse model of oxidative stress
por: Brown, Jacob L., et al.
Publicado: (2020)

Elevated phospholipid hydroperoxide glutathione peroxidase (GPX4) expression modulates oxylipin formation and inhibits age-related skeletal muscle atrophy and weakness
por: Czyżowska, Agnieszka, et al.
Publicado: (2023)

Neuron specific reduction in CuZnSOD is not sufficient to initiate a full sarcopenia phenotype
por: Sataranatarajan, Kavithalakshmi, et al.
Publicado: (2015)

The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging
por: Walsh, Michael E., et al.
Publicado: (2015)

Role of DNA methylation in the dietary restriction mediated cellular memory
por: Unnikrishnan, Archana, et al.
Publicado: (2017)

Mitochondrial oxidative stress impairs contractile function but paradoxically increases muscle mass via fibre branching
por: Ahn, Bumsoo, et al.
Publicado: (2019)

Reduced adenosine diphosphate sensitivity in skeletal muscle mitochondria increases reactive oxygen species production in mouse models of aging and oxidative stress but not denervation
por: Pharaoh, Gavin, et al.
Publicado: (2021)

Novel role of cPLA(2)α in membrane and actin dynamics
por: Moes, Maarten, et al.
Publicado: (2010)

Lipid hydroperoxides promote sarcopenia through carbonyl stress
por: Eshima, Hiroaki, et al.
Publicado: (2023)

Acylated Ghrelin Receptor Agonist HM01 Decreases Lean Body and Muscle Mass, but Unacylated Ghrelin Protects against Redox-Dependent Sarcopenia
por: Ranjit, Rojina, et al.
Publicado: (2022)

Lifelong reduction in complex IV induces tissue‐specific metabolic effects but does not reduce lifespan or healthspan in mice
por: Deepa, Sathyaseelan S., et al.
Publicado: (2018)

cPLA(2)α Enzyme Inhibition Attenuates Inflammation and Keratinocyte Proliferation
por: Ashcroft, Felicity J., et al.
Publicado: (2020)

Involvement of the γ Isoform of cPLA(2) in the Biosynthesis of Bioactive N-Acylethanolamines
por: Guo, Yiman, et al.
Publicado: (2021)

Oxidative stress‐induced dysregulation of excitation–contraction coupling contributes to muscle weakness
por: Qaisar, Rizwan, et al.
Publicado: (2018)

Long-Term Lithium Treatment Increases cPLA(2) and iPLA(2) Activity in Cultured Cortical and Hippocampal Neurons
por: De-Paula, Vanessa de Jesus, et al.
Publicado: (2015)

Cyclin-Dependent Kinase 5 Regulates cPLA2 Activity and Neuroinflammation in Parkinson’s Disease
por: Paul, Sangita, et al.
Publicado: (2022)

Nrf2 deficiency exacerbates age-related contractile dysfunction and loss of skeletal muscle mass
por: Ahn, Bumsoo, et al.
Publicado: (2018)

Using MRI to measure in vivo free radical production and perfusion dynamics in a mouse model of elevated oxidative stress and neurogenic atrophy
por: Ahn, Bumsoo, et al.
Publicado: (2019)

LRP1 Controls cPLA(2) Phosphorylation, ABCA1 Expression and Cellular Cholesterol Export
por: Zhou, Li, et al.
Publicado: (2009)

Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A(2) (GIVA cPLA(2))
por: Psarra, Anastasia, et al.
Publicado: (2018)

Antiplatelet Effect of Daphnetin Is Regulated by cPLA(2)-Mediated Thromboxane A(2) Generation in Mice
por: Chaudhary, Preeti Kumari, et al.
Publicado: (2023)

Sexually divergent DNA methylation patterns with hippocampal aging
por: Masser, Dustin R., et al.
Publicado: (2017)

Epidural Dexamethasone Decreased Inflammatory Hyperalgesia and Spinal cPLA(2) Expression in a Rat Formalin Test
por: Min, Sam-Hong, et al.
Publicado: (2014)

Lipopolysaccharide promoted proliferation and adipogenesis of preadipocytes through JAK/STAT and AMPK-regulated cPLA2 expression
por: Chang, Chao-Chien, et al.
Publicado: (2019)

cPLA2 activation contributes to lysosomal defects leading to impairment of autophagy after spinal cord injury
por: Li, Yun, et al.
Publicado: (2019)

Correction to “Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A(2) (GIVA cPLA(2))”
por: Psarra, Anastasia, et al.
Publicado: (2019)

Detection and Differentiation of Breast Cancer Sub-Types using a cPLA2α Activatable Fluorophore
por: Chiorazzo, Michael G., et al.
Publicado: (2019)

Targeting ROS and cPLA2/COX2 Expressions Ameliorated Renal Damage in Obese Mice with Endotoxemia
por: Chang, Jia-Feng, et al.
Publicado: (2019)

PLA2G4A/cPLA2-mediated lysosomal membrane damage leads to inhibition of autophagy and neurodegeneration after brain trauma
por: Sarkar, Chinmoy, et al.
Publicado: (2019)

Structure Activity Relationship and Molecular Docking of Some Quinazolines Bearing Sulfamerazine Moiety as New 3CLpro, cPLA2, sPLA2 Inhibitors
por: Hussein, Mohammed Abdalla, et al.
Publicado: (2023)

Inhibition of the MEK1/ERK pathway reduces arachidonic acid release independently of cPLA(2) phosphorylation and translocation
por: Evans, John H, et al.
Publicado: (2002)

Inhibition of Cytosolic Phospholipase A(2)α (cPLA(2)α) by Medicinal Plants in Relation to Their Phenolic Content
por: Arnold, Eva, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bhjsm3n0i6sjudn20kpscs7ulc